Glass Jacobson Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-135
Closed -$6.51K 804
2025
Q1
$6.51K Hold
135
﹤0.01% 645
2024
Q4
$6.51K Buy
135
+59
+78% +$3K ﹤0.01% 645
2024
Q3
$4.38K Hold
76
﹤0.01% 641
2024
Q2
$3.69K Hold
76
﹤0.01% 636
2024
Q1
$3.69K Hold
76
﹤0.01% 639
2023
Q4
$3.78K Sell
76
-75
-50% -$3.67K ﹤0.01% 612
2023
Q3
$8.1K Buy
151
+12
+9% +$640 ﹤0.01% 517
2023
Q2
$7.49K Buy
+139
New +$7.48K ﹤0.01% 536
2022
Q4
$6.54K Buy
+135
New +$5.93K ﹤0.01% 558

Other funds holding SNY

Glass Jacobson Investment Advisors's SNY Position: Q2 2025 in Review

Glass Jacobson Investment Advisors sold out of Sanofi (SNY) in Q2 2025, closing a stake of 135 shares — an estimated $6.51K sold.

Glass Jacobson Investment Advisors first reported a position in SNY in Q4 2022 and held it in 9 quarters. The position peaked at $8.1K in Q3 2023. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Glass Jacobson Investment Advisors reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Glass Jacobson Investment Advisors sold 135 Sanofi shares in Q2 2025, an estimated $6.51K.
  • Glass Jacobson Investment Advisors first reported a position in Sanofi in Q4 2022 and held it in 9 quarters.
  • Glass Jacobson Investment Advisors's Sanofi position peaked at $8.1K in Q3 2023.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.